DARA BIOSCIENCES INC's gross profit margin for the third quarter of its fiscal year 2015 is essentially unchanged when compared to the same period a year ago. Even though sales increased, the net income has decreased, representing a decrease to the bottom line. DARA BIOSCIENCES INC has strong liquidity. Currently, the Quick Ratio is 1.69 which shows the ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.
At the same time, stockholders' equity ("net worth") has significantly decreased by 63.01% from the same quarter last year. The key liquidity measurements indicate that the company is unlikely to face financial difficulties in the near future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q3 FY15||Q3 FY14|
|Net Sales ($mil)||1.18||0.6|
|Net Income ($mil)||-2.7||-2.11|
|Balance Sheet||Q3 FY15||Q3 FY14|
|Cash & Equiv. ($mil)||4.66||14.0|
|Total Assets ($mil)||9.68||18.53|
|Total Debt ($mil)||0.02||0.03|
|Profitability||Q3 FY15||Q3 FY14|
|Gross Profit Margin||79.59||78.93|
|Return on Assets||-105.15||-52.37|
|Return on Equity||-165.02||-58.17|
|Debt||Q3 FY15||Q3 FY14|
|Share Data||Q3 FY15||Q3 FY14|
|Shares outstanding (mil)||19.76||19.59|
|Div / share||0.0||0.0|
|Book value / share||0.31||0.85|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||79856.0||140864.0|
SELL. This stock’s P/E ratio is negative, making its value useless in the assessment of premium or discount valuation, only displaying that the company has negative earnings per share. To use another comparison, its price-to-book ratio of 3.01 indicates valuation on par with the S&P 500 average of 2.72 and a significant discount versus the industry average of 15.41. The price-to-sales ratio is well above the S&P 500 average, but well below the industry average. After reviewing these and other key valuation criteria, DARA BIOSCIENCES INC proves to trade at a discount to investment alternatives within the industry.
|DARA NM||Peers 44.55||DARA NM||Peers 39.08|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
DARA's P/E is negative making this valuation measure meaningless.
Neutral. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
DARA's P/CF is negative making the measure meaningless.
|DARA NM||Peers 18.56||DARA NA||Peers 0.54|
Neutral. The absence of a valid price-to-projected earnings ratio happens when a stock can not be valued on the basis of a negative expected future earnings.
DARA's ratio is negative making this valuation measure meaningless.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|DARA 3.01||Peers 15.41||DARA 53.58||Peers 15.10|
Discount. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
DARA is trading at a significant discount to its peers.
Higher. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
DARA is expected to have an earnings growth rate that significantly exceeds its peers.
|DARA 5.25||Peers 364.56||DARA 162.17||Peers 61.55|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
DARA is trading at a significant discount to its industry on this measurement.
Higher. A sales growth rate that exceeds the industry implies that a company is gaining market share.
DARA has a sales growth rate that significantly exceeds its peers.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.